Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma

Exclusion Criteria

• •1. Manifest cardiac insufficiency, not compensated
• •2. Congestive Cardiomyopathy
• •3. Chronic pulmonary disease including hypoxemia
• •4. Severe hypertension, not condensable with drugs
• •5. Severe diabetes mellitus not condensable with drugs
• •6. Renal Insufficiency ( serum creatinin \> 2,0 mg/dl, other than Lymphoma related)
• •7. Liver impairment ( Transaminases value more than 3 x upper normal value or Bilirubin \> 2,0 mg/dl, other than Lymphoma related)
• •8. HIV-Infection
• •9. Active Hepatitis B-Infection if continuous virostatic treatment is not possible
• •10. Active Hepatitis C-Infection
• •11. Clinical signs of cerebrovascular insufficiency or cerebral damages
• •12. Pregnancy, lactation or inadequate contraception in women of childbearing age
• •13. Severe psychiatric disorders
• •14. Transplantation in the past